FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to urology, and concerns therapy of patients suffering from chronic prostatitis. It is ensured by treatment of prostatitis including 4-5 physiotherapeutic courses every 6 months. Each course is preceded with blood test for testosterone concentration. If it is 12-18 nmol/l, preparation Nebido is prescribed in a dose 1000 mg. In case concentration exceeds 18 nmol/l, Nebido injection is omitted.
EFFECT: due to pulse introduction mode, therapy provides stimulation of androgen-dependent body functions in relative androgen deficiency and therefore improved clinical effectiveness of chronic prostatitis treatment with reduced drug body burden.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS SUFFERING FROM CHRONIC PROSTATITIS WITH PARTIAL ANDROGEN DEFICIENCY | 2013 |
|
RU2525182C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF FORM OF ERECTILE DYSFUNCTION | 2011 |
|
RU2460462C1 |
METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS | 2004 |
|
RU2281101C2 |
METHOD OF SELECTING PREPARATION FOR TREATMENT OF ERECTILE DYSFUNCTION | 2011 |
|
RU2456912C1 |
ESTIMATION METHOD OF PROSTATE CIRCULATION | 2008 |
|
RU2366364C1 |
METHOD FOR TREATMENT OF PATIENTS AFFECTED WITH CHRONIC PROSTATITIS AND DEVICE ITS REALIZATION | 2001 |
|
RU2203109C2 |
METHOD FOR DETERMINATION OF TREATMENT STRATEGY FOR LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA AGAINST THE BACKGROUND OF TESTOSTERONE DEFICIENCY | 2022 |
|
RU2795840C1 |
METHOD OF TREATING PROSTATOPATHY AND DEVICE FOR IMPLEMENTATION THEREOF | 2009 |
|
RU2428223C2 |
METHOD FOR TREATING CHRONIC PROSTATITIS | 2001 |
|
RU2203673C2 |
METHOD OF UROLITHIASIS RECURRENCE TREATMENT AND PREVENTION FOR MEN | 2008 |
|
RU2371182C1 |
Authors
Dates
2009-08-20—Published
2008-04-28—Filed